Most material SEC filings — August 31, 2026

As of August 30, 2026, Bitmine reports crypto + cash holdings of $15.6 billion, comprising 5,901,112 ETH tokens ($14.8B at $2,511/token), 211 BTC, $180M Beast Industries stake, $81M Eightco (ORBS) stake, and $541M cash/marketable securities. The company has staked 5,067,309 ETH ($12.7B) generating projected annualized staking revenue of $340M ($396M at full scale). Bitmine acquired 53,501 ETH in the past week and has bought ETH every week for 65 consecutive weeks since June 30, 2025.

Cenntro Inc. agreed to issue 12,800,000 shares of common stock at $3.773 per share (5-day VWAP) for aggregate proceeds of $48,294,400 in a private placement under Regulation S, dated August 25, 2026. Purchasers are non-U.S. persons; shares include restrictive legends and 6-month distribution compliance period. No specific purchaser names disclosed in this exhibit; individual purchaser details appear on signature pages not included here.

Flag Ship Acquisition Corp (market cap ~$72M) filed an 8-K on August 31, 2026, disclosing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, with a transfer of listing. No specific dollar amounts, counterparties, or detailed reasons are provided in the filing header or available text excerpts.

Microvast Holdings, Inc. filed an 8-K on August 31, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, with a Transfer of Listing. The filing indicates the company has received formal notification of a delisting or listing compliance failure, though specific reasons, timelines, remediation steps, and the destination exchange (if any) are not disclosed in the provided document excerpt.

Helix Energy Solutions Group shareholders approved the all-stock combination with Hornbeck Offshore Services on August 31, 2026, with transaction expected to close September 1, 2026. Upon completion, Hornbeck shareholders will own ~55% and Helix shareholders ~45% of combined entity on fully diluted basis. Combined company will operate as Hornbeck Offshore Services, Inc. trading under ticker HOS on NYSE.

Tenon Medical (market cap ~$7.3M) is conducting a private placement of up to $3M in common stock, pre-funded warrants, and Series A warrants at $5.02/share. Investors receive shares plus Series A warrants (150% coverage at $5.02 exercise price) and optional pre-funded warrants ($0.001 exercise). WallachBeth Capital LLC is placement agent (7% cash fee + $65K expenses). Closing contingent on standard reps, no Material Adverse Effect, and registration statement filing within 15 days.

PMV Pharmaceuticals announced interim Phase 2 PYNNACLE trial data for rezatapopt in platinum-resistant/refractory ovarian cancer: 46% overall response rate (35/76 patients), median duration of response 10.0 months, favorable safety profile with 5% discontinuation due to adverse events. FDA feedback supports NDA submission strategy for accelerated approval; company plans to submit NDA in Q1 2027.

Callan Power LLC (subsidiary of Callan JMB Inc., $7.4M market cap) agreed to purchase 50% of The Pfanenstiel Company LLC's oil and gas leases and wells in North Dakota and Montana for $12.5M cash plus $1M escrow. Deal dated August 26, 2026; execution price appears ~169% of company's market value. Transaction includes ~74,204 gross acres of leases and hundreds of wells across multiple operators (Hess, Oasis, Whiting, Continental, Devon, EOG, others), with Callan receiving proportional working interests ranging from <0.1% to ~12.8% per well.

Sermonix Pharmaceuticals, Inc. (Delaware corporation, CIK 0001655566) filed a Schedule 13D on 2026-08-31 regarding beneficial ownership in LeonaBio, Inc. (public market value ~$9.9M, CIK 0001620463). The filing includes a joint filing agreement and powers of attorney from Sermonix and David Portman, but the specific ownership percentage, share count, dollar amount, and nature of the acquisition are not disclosed in the metadata provided—the actual Schedule 13D document text is not included in this filing extract.

Sono Group N.V. (market cap ~$7.2M) completed a registered direct offering of 283,500 ordinary shares (19.9% of outstanding) at market price for $530,000 total ($1.87/share implied), with no discount or warrants. Concurrent with this capital raise, the company signed a non-binding letter of intent to combine with Sports One, a sports franchise ownership and intelligence platform. Key investors include Paul Misir ($250K for 93,633 shares), Chris Kelly ($150K for 56,180 shares), and others. The merged entity would be renamed Sports One, with Sports One equity holders receiving a super-majority stake. Close contingent on due diligence, definitive agreements, regulatory approval, and shareholder vote. Investors committed to 180-day lock-up.

Mobix Labs (market cap ~$30.5M) signed a definitive agreement to acquire Vision Aerial, a Bozeman-based drone manufacturer founded in 2013. Vision Aerial projects 46% revenue growth in 2026 and 93% in 2027, serving U.S. Navy, L3Harris, and infrastructure customers. The transaction is expected to close Q4 2026 subject to stockholder approval; acquisition consideration (share count and dollar amount) is not disclosed in this filing.

On August 28, 2026, T3 Defense unwound its July 6, 2026 acquisition of a 60% equity stake in Project 35 Ltd. from XSA Security and Defense Ltd. T3 returned the Purchased Shares to XSA; XSA returned 168,479 shares of T3 common stock (post-reverse split) and a cancelled promissory note to T3. Both parties released all claims and the Stock Purchase Agreement was terminated entirely.

Vice Chairman Howard Jonas led a ~$7.5M direct investment in Zedge (purchase price tied to Class B stock closing; 90% warrant coverage at 110% exercise price; 5-year term; expected to close within 10 days). Morris Berger appointed CEO effective October 1, 2026, replacing current CEO Jonathan Reich, who transitions to President/COO. Investment aims to accelerate DataSeeds.AI growth—Zedge's B2B AI data business—through talent recruitment, technology expansion, and selective acquisitions.

GameStop amended its convertible notes exchange with existing noteholders, fixing settlement at approximately 55.5 million shares of Class A common stock (73% of consideration) and $358.4 million cash (27%), down from an all-stock structure. The $1.4 billion principal amount exchange closes ~September 3, 2026, leaving ~$2.8 billion in convertible notes outstanding. Q2 2026 preliminary results show net sales of $780–800M (vs. $972M prior year), operating income $150–170M (vs. $66.4M), and net income $290–310M (vs. $168.6M); the company holds 43.4M eBay shares worth ~$4.947B, with ~$238M of net eBay-related gains offsetting ~$75M digital asset losses.

Ranger Energy Services agreed to acquire STEP Energy Services' U.S. coiled tubing assets for ~$27.5M ($22.5M cash + $5M equity), closing ~September 11, 2026. The deal includes 13 coiled tubing spreads, ~220 employees, and assets across Permian/Bakken. Pro forma, Ranger adds $80–90M revenue and $10M+ EBITDA in 2027 with $2.5M+ first-year synergies; expected accretive to 2027 earnings.

Roberto Cuca, COO/CFO, stepped down effective August 31, 2026. TELA Bio announced a cost reduction initiative targeting $17.0 million in annual operating expense reductions (18% of operating costs) through ~20% headcount reduction and external resource streamlining. One-time restructuring charge of ~$1.5 million expected in Q3 2026; company expects cost cuts to extend cash runway into 2028.

On August 17, 2026, Zhibao issued 395,678,152 PIPE units (each: one Class A share + one warrant) to unnamed selling shareholders for $154.7M paid in 2,380 Bitcoin (at $65k reference price). The company also registered 395,678,152 warrant shares for resale. Combined with existing shares, resale represents 180.28% of outstanding shares as of August 26, 2026 ($0.18/share). Company received no proceeds from resales but could receive ~$138.5M if all warrants exercised at $0.35/share. A second tranche of 46.3M units may follow upon condition satisfaction.

Cadrenal announced positive feedback from July 28, 2026 Type D FDA meeting on CAD-1005, a first-in-class 12-LOX inhibitor for heparin-induced thrombocytopenia. FDA agreed on optimized primary endpoint (proportion of SRA-positive patients with new/worsening thromboembolic events through Day 14 or discharge) and placebo-controlled trial design. The indication targets ~50,000 annual acute HIT cases in US with estimated $2B peak annual revenue opportunity.

Castellum's subsidiary GTMR received a $32.8 million modification to its existing NAVAIR PMA-290 Special Missions contract under the SeaPort-NxG vehicle, increasing the total contract ceiling from $103.4M to $136.2M. Of this modification, $1.1 million is currently funded with work expected complete by March 2027; the remaining $31.7 million is subject to future tasking and funding availability. The expanded scope covers technical and programmatic support for multiple Navy ISRT programs including P-8A, MQ-4C Triton, and maritime reconnaissance platforms.

Cohen Company, LLC amended and restated its senior promissory note with JKD Capital Partners I LTD from the original principal of $5,145,926.67 (dated September 1, 2024) to $5,000,000.00 as of August 31, 2026. The restructuring consolidated unpaid principal and interest of $2,625,409.50 plus an additional $2,374,590.50 cash infusion. The note matures August 31, 2027, accrues interest at 10% annually (11% upon default), and restricts the company from incurring senior indebtedness or prepaying before January 31, 2027.

On July 28, 2026, Onconetix issued 37,812 shares of Series F Preferred Stock to Seven Knots LLC for $30,249,600 aggregate purchase price ($249,600 cash + $30,000,000 commitment fee cancellation). The Series F converts to up to 100,000,000 common shares at $0.9767/share, but current Nasdaq rules limit conversion to 789,426 shares (representing ~19.99% of pre-issuance outstanding). This S-1/A registers resale of up to 100,000,000 common shares issuable upon conversion. Company had $5.1M cash as of August 28, 2026, and substantial doubt about going concern.

Endovia Health Sciences (market cap ~$6.5M) announced it will submit a CannEpil pre-submission conference request to the FDA in the coming week, positioning its CBD/THC cannabinoid formulation for regulated pharmaceutical development. The company welcomed the federal government's support for rescheduling marijuana from Schedule I to Schedule III during DEA proceedings, viewing it as removing historical impediments to cannabinoid research. Endovia is concurrently evaluating additional cannabinoid formulations and seeking expanded financing to support pipeline development and potential acquisitions.

Kyntra Bio amended its royalty financing agreement with NQ Project Phoebus, L.P., reducing maximum aggregate payments from $125M to $65M. The company made a $42.6M upfront payment (bringing total paid to $50M, fully returning the investor's capital), with remaining obligations capped at $15M paid from 50% of Astellas EVRENZO revenues. Pro forma cash position: $53.1M as of June 30, 2026, extending runway to Q4 2027.

iSpecimen Inc. engaged Shahin Behroyan (through his BC corporation 1605811 BC Ltd.) as independent contractor CEO effective August 26, 2026, at $350,000 USD annually ($29,166.67/month). The agreement provides $67,500 severance if terminated without cause or if contractor resigns for good reason. Contractor remains independent (no employee benefits, no employer-employee relationship) and may work remotely or on-site.

Americold completed its joint venture with EQT's Active Core Infrastructure fund on August 31, 2026. EQT acquired 70% ownership of Americold-EQT Cold Storage Partnership, LLC (12 facilities, $1.3B gross asset value) while Americold retains 30% and operates the platform. Americold received ~$1.1B net cash proceeds, which it plans to use for debt repayment and balance sheet strengthening. A First Amendment to the Contribution Agreement (dated August 29, 2026) modified restructuring mechanics, asset allocations, and customer contract definitions, with no change to gross asset value or contribution amounts.

Inflection Point Acquisition Corp. V (IPACV, ~$87M market cap) executed three amendments on August 31, 2026 to its pending business combination with GOWell Technology Limited. The amendments materially modify lock-up and transfer restrictions: (1) Section 8.20 of the Business Combination Agreement replaced to establish new Lock-Up Agreement form for all Company shareholders at closing; (2) SPAC Holders Support Agreement Section 1.6 modified to reference New Registration Rights Agreement; (3) most significantly, Omnibus Amendment to Insider and Underwriting Agreements eliminates all lock-up restrictions and transfer restrictions on Private Placement Units for insiders/sponsors and underwriters effective at business combination closing. No dollar amounts, share counts, or percentage details disclosed in the amendments themselves.

StableCoinX Inc. (assets $232.6M) filed S-1 registration on August 31, 2026 for IPO comprising: 19.1M warrant shares (11.5M public warrants at $11.50/share; 3.3M Tranche A sponsor warrants at $11.50/share; 4.4M Tranche B sponsor warrants at $15.00/share) plus 12.7M secondary shares from selling stockholders (4.97M business combination shares, 78.6K RSU shares, 7.62M sponsor warrant shares). Auditor noted going-concern qualifications for both StableCoinX Inc. and StableCoinX Assets Inc.

SLB signed an agreement to acquire Kelvion, a thermal management and heat exchange technology provider, from Apollo-managed funds (majority owner) and Triton-advised funds (minority) for approximately $3.4 billion in cash plus assumption of ~$0.7 billion debt (total ~$4.1 billion enterprise value, ~11x 2026 EBITDA pre-synergies). Kelvion generated ~$2.3–$2.4 billion revenue and ~$350–$400 million adjusted EBITDA in 2026, with data centers representing $1.2–$1.3 billion. SLB expects ~$120 million annual EBITDA synergies within three years and targets combined data center revenue of $4.5–$5 billion and $700–$800 million adjusted EBITDA by 2028. Close expected H1 2027; accretion to EPS and free cash flow expected within 12 months; net debt-to-EBITDA to remain ≤1.5x.

Director RAKOLTA JOHN JR (ADC) bought 20K shares (~$1.5M) on the open market (3.1% of holdings). Open-market insider purchase — historically a bullish signal.

MicroVision received written notice from Nasdaq on August 26, 2026, confirming regained compliance with Listing Rule 5550(a)(2), which requires a minimum bid price of $1 per share. The company had been in noncompliance since January 12, 2026. Nasdaq has closed the matter.

CEO and Chair Liu Dandan (PETZ) bought 3.0M shares (~$3.6M) on the open market (37% of holdings). Open-market insider purchase — historically a bullish signal.

BranchOut Food completed the full exercise of underwriters' over-allotment option on August 31, 2026, selling an additional 123,088 shares at $3.40/share for approximately $418,500 in gross proceeds. Total public offering now 943,676 shares generating ~$3.2M gross proceeds (before underwriting fees and expenses). Lake Street Capital Markets was underwriter representative.

Director Courtis Kenneth S. (AMR) bought 5K shares (~$1.1M) on the open market (0.5% of holdings). Open-market insider purchase — historically a bullish signal.

10% owner Opaleye Management Inc. (SLGL) bought 40K shares (~$2.8M) on the open market (7.1% of holdings). Open-market insider purchase — historically a bullish signal.

On March 2, 2026, Malibu Boats acquired Saxdor (premium adventure dayboat brand) for net consideration of ~$118.3M cash and ~$41.7M in Class A shares plus contingent consideration (~$32.6M). FY2026 net sales rose 13.3% to $914.6M (+$107M), but GAAP net income collapsed 88.8% to $1.7M (from $15.2M) due to acquisition integration costs ($14.8M), amortization step-up ($3.1M), and margin compression from inflationary material/labor costs. The Board authorized a $70M share repurchase program for FY2027 (paused during refinancing; credit facility extended to July 2031).

KPMG LLP, Crown Crafts' principal auditor, was dismissed on August 27, 2026, after reporting on FY2026 and FY2025 consolidated financials (dated June 24, 2026). KPMG's dismissal letter states disagreement with certain management claims regarding Audit Committee approval and pre-change consultation with Grant Thornton. No successor auditor is named in this 8-K filing.

On July 1, 2026, Prosperity Bancshares completed its acquisition of Stellar Bancorp, issuing 19.4 million shares (0.3803 per Stellar share at $73.03/share = $1.415B equity) and paying $578.7M cash ($11.36/share). Total preliminary consideration: $1.993B. Pro forma combined assets: $54.2B (vs. Prosperity standalone $43.6B). Preliminary goodwill: $733.7M. Direct transaction costs: $63M.